Ikarian Capital, LLC Curis Inc Call Options Transaction History

Ikarian Capital, LLC

  • $247 Million
  • Q2 2024

Call Options

3 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2021

Aug 16, 2021
SELL
$7.45 - $16.27 $745,000 - $1.63 Million
-100,000 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$8.78 - $12.8 $3.62 Million - $5.28 Million
-412,500 Reduced 80.49%
100,000 $1.13 Million
Q4 2020

Feb 12, 2021
BUY
$1.08 - $8.2 $553,500 - $4.2 Million
512,500 New
512,500 $4.2 Million

About CURIS INC

CRIS Quotes by TradingView
  • Ticker CRIS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,814,704
  • Market Cap $393M
  • Description
  • Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...
More about CRIS
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email